Levomenol
Drug profile
Also known as: (-)-alpha-Bisabolol, bisabolol, kamillosan
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Levomenol is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including CHRNA7 and STAT3.
- Molecular targets: CHRNA7 and STAT3 (2 listed in DrugCentral).
- Molecular formula: C15H26O; molecular weight 222.37 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Neuronal acetylcholine receptor subunit alpha-7 | CHRNA7 | unknown | IC50 5.51 |
| Signal transducer and activator of transcription 3 | STAT3 | unknown | IC50 4.14 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
Chemical structure
| Molecular formula | C15H26O |
|---|---|
| Molecular weight | 222.37 g/mol |
| CAS number | — |
| InChIKey | RGZSQWQPBWRIAQ-CABCVRRESA-N |
| PubChem CID | 442343 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Levomenol work?
Its molecular targets in DrugCentral include CHRNA7 and STAT3.
What is the chemical formula of Levomenol?
Levomenol has the molecular formula C15H26O and a molecular weight of 222.37 g/mol.
Browse: all drugs starting with L · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4619 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1096927 — compound record and bioactivity
- PubChem CID 442343 — chemical identifiers
- DrugBank DB13153 — drug record
- FDA UNII 24WE03BX2T — substance identity
- DailyMed: FDA labels for Levomenol — current prescribing information (label search)
- UniProt P36544 (CHRNA7) — target protein
- UniProt P40763 (STAT3) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.